AccessMyLibrary provides FREE access to millions of articles from top publications available through your library.
Close
Create a link to this page
Copy and paste this link tag into your Web page or blog:
<a href="http://www.accessmylibrary.com/coms2/summary_0286-30631300_ITM" title="Facts and information about Seroquel approved for bipolar depression.(Briefly Noted)">Seroquel approved for bipolar depression.(Briefly Noted)</a>
Close
Set up an RSS feed that alerts you when new articles from Mental Health Weekly are available.
Frequently asked questions about RSS feeds
Seroquel approved for bipolar depression.(Briefly Noted)
AstraZeneca Plc. announced the October 20 Food and Drug Administration approval of Seroquel (quetiapine fumarate) to be marketed as a treatment for bipolar depression, reported Reuters (Oct. 20). Classified as an atypical antipsychotic medication, Seroquel was already approved for the treatment of acute manic episodes associated with bipolar disorder and for the treatment of schizophrenia. The new approval makes Seroquel the first …
Related articles from newspapers, magazines, journals, and more
-
- BOLDER II STUDY CONFIRMS THERAPEUTIC POTENTIAL OF SEROQUEL IN BIPOLAR...
-
News wire article from: Asia Africa Intelligence Wire
October 21, 2005
700+ words
-
- FDA approves AstraZeneca's Seroquel XR for the treatment of bipolar...
-
News wire article from: Chemical Business Newsbase
October 10, 2008
700+ words
-
- BOLDER II study confirms therapeutic potential of Seroquel in bipolar...
-
News wire article from: Asia Africa Intelligence Wire
October 21, 2005
700+ words
-
- Data further examines Seroquel (quetiapine fumarate) treatment for bipolar...
-
News wire article from: Asia Africa Intelligence Wire
May 24, 2005
700+ words
-
- FDA approves AstraZeneca's Seroquel for bipolar depression treatment.
-
News wire article from: Chemical Business Newsbase
October 20, 2006
700+ words
